Zuber khan

About

Zuber Khan is currently working as Ph.D research scholar in the division of neuroscience, Department of Pharmacology, at ISF College of Pharmacy in Moga, Punjab, India (affiliated to I. K. Gujral Punjab Technical University). He did his M. Pharmacy in Pharmacology from SPER, Jamia Hamdard, New Delhi, in 2022. He graduated from MVN University, Palwal, Haryana. He qualified pharmacy entrance exams and scored 91.4 in GPAT and AIR 695 in NIPER JEE in 2020. His research focuses on neuroscience, neurodegenerative disorders, and neuropharmacology. He has participated in various reputed national and international conferences such as international conference of Bulgarian society of Physiological science, Society of Neurochemistry International (SNCI), New Delhi, India, 5th National Convention of APTI, punjab, 4th Asian congress for Alternatives to Animal Experimentds (4ACAAE), Jamia Hamdard, New Delhi.
He has published many papers, including research and reviews and book chapters in various reputed journals like Frontiers in Pharmacology, Brain Research, Behavioural brain research, Neurochemistry international, Biochemical Pharmacology, journal of Neuroimmunology, Neurotoxicology, Neurochemical Research, molecular Neurobiology, Heliyon, Naunyn-Schmiedeberg's archives of pharmacology, Biogerontology, Current Alzheimer research, Journal of clinical medicine etc.
 

Employment

• Indo Soviet Friendship College of Pharmacy Research Scholar
  2022 - Present

Education

• MVN University B.Pharm
  2016 - 2020

Projects & Funding

Projects & funding information is unavailable.

Publications (50)

• Targeting the microbiota-gut-brain axis in neurodegeneration: Zebrafish-based investigations
  Neurodegenerative Disease Management 2026 0 citations DOI: 10.1080/17582024.2026.2705869
  +Save
• Decoding the PI3K/Akt/mTOR–JAK/STAT signaling axis in multiple sclerosis: mechanistic crosstalk and therapeutic opportunities
  Immunologic Research 2026 0 citations DOI: 10.1007/s12026-026-09808-9
  +Save
• Neoantigen in cancer immunotherapy: mechanism, therapeutic strategies and future perspectives
  Immunotherapy 2026 0 citations DOI: 10.1080/1750743X.2026.2721185
  +Save
• The Neurological Risks of Long-Term PPI Use: Dementia, Gut-Brain Axis, and Vitamin B12 Deficiency
  Current Behavioral Neuroscience Reports 2026 0 citations DOI: 10.1007/s40473-026-00326-4
  +Save
• Neurosyphilis and Parkinsonism: Overlapping Pathophysiology and Emerging Therapeutic Insights
  Current Neurovascular Research 2026 0 citations DOI: 10.2174/0115672026455328260209113932
  +Save
• Nipah and chandipura viruses: Emerging neurotropic zoonotic viruses in south asia — a comparative review
  Molecular Biology Reports 2026 3 citations DOI: 10.1007/s11033-026-11469-8
  +Save
• Therapeutic potential of Baicalin against experimental obsessive compulsive disorder: Evidence from CSF, blood plasma, and brain analysis
  Journal of Neuroimmunology 2025 4 citations DOI: 10.1016/j.jneuroim.2025.578598
  +Save
• Postbiotics and Metabolic Signaling in Colorectal Cancer
  Cancer Drug Discovery and Development 2025 0 citations DOI: 10.1007/978-3-031-86065-2_4
  +Save
• The SIRT-1/Nrf2/HO-1 axis: Guardians of neuronal health in neurological disorders
  Behavioural Brain Research, Elsevier 2025 50 citations DOI: 10.1016/j.bbr.2024.115280
  +Save
• Disruptions in cellular communication: Molecular interplay between glutamate/NMDA signalling and MAPK pathways in neurological disorders
  Neuroscience 2025 16 citations DOI: 10.1016/j.neuroscience.2025.01.021
  +Save